The Analysis Of Pharmaceutical Enterprises' Financing Question Of China

The pharmaceutical enterprise holds the more and more important status in the drugs manufacture domain, the various countries especially west developed country all regards it to perform the key support in particular for the strong economical growth spot. Compared with western countries in particular US, the biological technology medicine development had the high risk, the high investment characteristic, financing difficult already becomes a key factor affecting our country pharmaceutical enterprise development. Its financing question not only involves the fund investment quantity, but also the mechanism question. Therefore solving our country pharmaceutica enterprise's financing problem, must take key to its new financing mechanism.According to the pharmaceutical enterprise's characteristic and the advanced experience of the western developed countries, this paper discusses the factors influencing the financing difficulty of the pharmaceutical enterprises in our country, and analyses the listed company's financing structure to the pharmaceutical enterprises by the comparative analysis method, then puts forward the optimized proposal to the pharmaceutical enterprise financing based on the modern financing structural theory by quantity research method. This research main innovation lies in systematically studies of each stage the financing way of The pharmaceutical enterprise in China and put forwards the financing strategies of listed and unlisted companies; this article is not only helpful to study the corresponding question of high tech enterprise in Chins, but also to the system reason of China further.This paper comprises five parts. Part 1 mainly introduces the goal and the significance, the research technique, as well as domestic and foreign financing structural theory research progress and concepts. In profits from the western developed country the pharmaceutical enterprises in the Financing Structure Theory, in Part 2, the pharmaceutical enterprises' the stages of financing structure change is elaborated, and the pharmaceutical enterprises' funds needing is analysed. In part 3,the financing characteristics of the pharmaceutical enterprises in the western developed country are discussed. In part 4, according to the policy environment of the pharmaceutical enterprises in our country ,the financing methods is elaborated ,and it's financing structure characteristic from the theory and the real diagnosis is discussed. In part 5, the proposal is put forward to the pharmaceutical enterprises ' financing environment. And we hope that we can improve financing institution of the pharmaceutical enterprises by deepening development of market-oriented reform and promoting financing innovation ,then improve financing structure of the pharmaceutical enterprises in our country to adapt to requirements of market competition .thereby promoting the progress of industrialization, industry upgrading and industrial structure transtion.